MAPT and Alzheimer disease: However, to the best of our knowledge, no studies directly tested parallelism of endogenous tau protein in CSF to validate these calculated concentrations as accurate measures of AD CSF tau surrogate peptide abundances using an immuno-enrichment free sample preparation approach.